2,2'-azobis(2-amidinopropane) has been researched along with Kidney Failure, Chronic in 1 studies
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The results thus suggest that a daily dosage of 2." | 2.68 | n-3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. ( Biasia, F; Biffanti, S; Bonanome, A; De Luca, M; Munaretto, G; Pagnan, A; Pradella, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonanome, A | 1 |
| Biasia, F | 1 |
| De Luca, M | 1 |
| Munaretto, G | 1 |
| Biffanti, S | 1 |
| Pradella, M | 1 |
| Pagnan, A | 1 |
1 trial available for 2,2'-azobis(2-amidinopropane) and Kidney Failure, Chronic
| Article | Year |
|---|---|
n-3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects.
Topics: Amidines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fatty Acids, Omega-3; Female; Humans; Hyp | 1996 |